#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Chronic myelomonocytic leukaemia Pulmonary sarcoidosis Insulinoma Inclusion body myositis Chronic lymphocytic leukaemia Hepatocellular carcinoma Bronchopulmonary dysplasia Bile acid synthesis disorder Liver abscess Malignant neoplasm of choroid Diffuse large B-cell lymphoma recurrent Hypophosphatasia Pyruvate dehydrogenase complex deficiency Gastrooesophageal cancer Bladder cancer More trials…

    Learn about Rare Diseases

    Rosai-Dorfman syndrome – Diagnostics Basal cell naevus syndrome – Treatment Von Willebrand’s disease – Life with Disease Netherton’s syndrome – Life with Disease Pemphigoid – Treatment Rhabdomyosarcoma Optic glioma – Trials in Disease Splenic marginal zone lymphoma – Treatment Pelizaeus-Merzbacher disease – Diagnostics Atypical haemolytic uraemic syndrome – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ciclosporin Rasburicase N-Tec Midomafetamine Hydrochloride ATTR-01 Naproxen Jnj-64042056 Lanifibranor Sufentanil Ht-29-A Farletuzumab Ecteribulin Regn7508 Olodaterol 18F-Psma-1007 Litenimod Sodium Ciprofloxacin RNK001 Specific Nucleic Acid Sna-Papi Isis 678354 Sodium Salt Vx-670 More therapies…

    Learn about Your Condition

    Hereditary ataxia Colon cancer Diabetic foot Poor quality sleep Metastases to biliary tract Primary hyperoxaluria Tricuspid valve disease Fabry's disease Neurodegenerative disorder Precocious puberty Glomerulonephritis chronic Tendon rupture Androgenetic alopecia Supranuclear palsy Dengue fever More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Osteoarthritis

  • Efficacy and Safety of LTG-321 Compared with Placebo in Patients with Osteoarthritis of the Knee

    Recruiting

    2 1
    Investigated Diseases:
    • Osteoarthritis
    Denmark

  • Efficacy of intra‑articular allogeneic peripheral blood mononuclear cells induced to an early apoptotic state versus placebo in adults with primary knee osteoarthritis

    Recruiting

    2 1
    Investigated Diseases:
    • Osteoarthritis
    Investigated Drugs:
    • Allogeneic Peripheral Blood Mononuclear Cells Induced To An Early Apoptotic State
    Denmark Poland

  • A study to evaluate the effects of zenagamtide on weight and pain in patients with overweight or obesity and knee osteoarthritis

    Recruiting

    3 1
    Investigated Diseases:
    • Obesity
    • Osteoarthritis
    • Overweight
    Bulgaria Denmark Greece Italy Poland Spain

  • A study to evaluate the efficacy and safety of zenagamtide in people with overweight or obesity and knee osteoarthritis

    Recruiting

    3 1
    Investigated Diseases:
    • Obesity
    • Osteoarthritis
    • Overweight
    Bulgaria Denmark Greece Italy Poland Spain

  • A Study of Orforglipron for Knee Pain Relief in Adults with Obesity or Overweight and Knee Osteoarthritis

    Recruiting

    3 1
    Investigated Diseases:
    • Osteoarthritis
    Germany Spain

  • A study comparing montelukast to placebo for reducing pain in patients with erosive osteoarthritis of the hands

    Recruiting

    3 1
    Investigated Diseases:
    • Osteoarthritis
    Investigated Drugs:
    • Montelukast
    Italy Portugal Spain
1 2 3 … 10
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!